...
首页> 外文期刊>Arteriosclerosis, thrombosis, and vascular biology >Effect of probucol in lecithin-cholesterol acyltransferase-deficient mice: inhibition of 2 independent cellular cholesterol-releasing pathways in vivo.
【24h】

Effect of probucol in lecithin-cholesterol acyltransferase-deficient mice: inhibition of 2 independent cellular cholesterol-releasing pathways in vivo.

机译:普罗布考对卵磷脂-胆固醇酰基转移酶缺陷小鼠的影响:体内抑制2个独立的细胞胆固醇释放途径。

获取原文
获取原文并翻译 | 示例
           

摘要

Cellular cholesterol release takes place by at least 2 distinct mechanisms: the lecithin-cholesterol acyltransferase (LCAT)-driven net efflux by cholesterol diffusion and the generation of high density lipoprotein (HDL) with cellular cholesterol and phospholipid on the cell-apolipoprotein interaction. Therefore, LCAT deficiency impairs the former pathway, and the latter can be inhibited by probucol, which interferes with the apolipoprotein-cell interaction. Hence, probucol was given to the LCAT-deficient mice in the attempt to suppress both of these pathways. The mice were fed low (0.2%) and high (1.2%) cholesterol diets containing 0.5% probucol for 2 weeks. LCAT deficiency and probucol markedly decreased plasma HDL, and the effects were synergistic. Tissue cholesterol content was lower in the adrenal glands and ovaries in the LCAT-deficient mice and in the probucol-treated mice, suggesting that HDL is a main cholesterol provider for these organs. It was also moderately decreased in the spleen of the low cholesterol-fed female mice and in the thyroid gland of the low cholesterol-fed male mice. On the other hand, the esterified cholesterol content in the liver was substantially increased by the probucol treatment with a high cholesterol diet in the LCAT-deficient mice but not in the wild-type mice. Among the groups, there was no significant difference in the tissue cholesterol levels in other organs, such as the liver, spleen, thymus, brain, erythrocytes, thyroid gland, testis, and aorta, resulting from either LCAT deficiency or probucol. Thus, the apolipoprotein-mediated mechanism plays a significant role in the export of cellular cholesterol in the liver, indicating that the liver is a major site of the HDL assembly. Otherwise, tissue cholesterol homeostasis can largely be maintained in mice even when the assembly of new HDL is inhibited by probucol in the absence of LCAT. Nonspecific diffusion of cholesterol perhaps adequately maintains the homeostasis in the experimental condition.
机译:细胞胆固醇的释放至少通过两种不同的机制发生:卵磷脂-胆固醇酰基转移酶(LCAT)通过胆固醇扩散驱动净流出,以及高密度脂蛋白(HDL)与细胞胆固醇和磷脂在细胞-载脂蛋白相互作用上的生成。因此,LCAT缺乏会破坏前者的通路,而后者可被普罗布考抑制,从而干扰载脂蛋白与细胞的相互作用。因此,将普罗布考给予LCAT缺陷型小鼠以试图抑制这两种途径。给小鼠喂食含0.5%普罗布考的低(0.2%)和高(1.2%)胆固醇饮食2周。 LCAT缺乏症和普罗布考显着降低血浆HDL,且具有协同作用。在LCAT缺陷型小鼠和经普罗布考治疗的小鼠中,肾上腺和卵巢中的组织胆固醇含量较低,这表明HDL是这些器官的主要胆固醇提供者。在低胆固醇喂养的雌性小鼠的脾脏和低胆固醇喂养的雄性小鼠的甲状腺中,其也适度降低。另一方面,在LCAT缺乏的小鼠中,通过高胆固醇饮食的普罗布考治疗,肝脏中的酯化胆固醇含量显着增加,而在野生型小鼠中则没有。在各组之间,由于LCAT缺乏或普罗布考而导致的其他器官(如肝,脾,胸腺,脑,红细胞,甲状腺,睾丸和主动脉)的组织胆固醇水平无显着差异。因此,载脂蛋白介导的机制在肝脏中细胞胆固醇的输出中起重要作用,表明肝脏是HDL装配的主要部位。否则,即使在没有LCAT的情况下普罗布考抑制了新HDL的组装,小鼠中的组织胆固醇稳态也可以在很大程度上维持。胆固醇的非特异性扩散也许可以在实验条件下充分维持体内稳态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号